The Discounted Cash Flow (DCF) valuation of Amedisys Inc (AMED) is 70.49 USD. With the latest stock price at 100.99 USD, the upside of Amedisys Inc based on DCF is -30.2%.
Based on the latest price of 100.99 USD and our DCF valuation, Amedisys Inc (AMED) is a sell. selling Amedisys stocks now will result in a potential gain of 30.2%.
| Range | Selected | |
| WACC / Discount Rate | 7.5% - 10.2% | 8.8% |
| Long-term Growth Rate | 1.0% - 3.0% | 2.0% |
| Fair Price | 53.23 - 106.09 | 70.49 |
| Upside | -47.3% - 5.1% | -30.2% |